Candida Tropicans BY PCR

The Candida Tropicans BY PCR is a molecular diagnostic test that detects the DNA of Candida tropicalis in clinical specimens using real-time polymerase chain reaction (PCR). It provides species-level identification with higher sensitivity and faster turnaround than traditional culture methods, enabling precise diagnosis of vulvovaginal candidiasis, candiduria, or other Candida-associated infections.

This test is particularly useful for people with recurrent or treatment-resistant yeast infections, patients with persistent UTI-like symptoms after antibiotics, and immunocompromised or diabetic individuals who are at higher risk of invasive fungal infections. With discreet home sample collection available across Dubai, results can guide targeted antifungal therapy and reduce unnecessary or ineffective treatments; physician consultation is recommended to interpret results and plan management.

• Candida tropicalis DNA (qualitative)
• Species-level identification
• Cycle threshold (Ct) value
• Internal control (sample integrity)

• Recurrent or persistent vaginal yeast infections
• UTI-like symptoms not responding to antibiotics
• Immunocompromised patients with suspected fungal infection
• Diabetics or patients on broad‑spectrum antibiotics with suspected candidiasis
• Failure of prior antifungal therapy or suspected resistant species

• Rapid, species-specific identification to guide antifungal choice
• Higher sensitivity and faster results compared with culture
• Discreet home sample collection across Dubai for patient convenience
• Reduces unnecessary antibiotic use and supports antifungal stewardship
• Confidential reporting with option for clinician follow-up in UAE

• Accepted samples: vaginal or urethral swab, or first-catch urine (follow collector instructions)
• Avoid topical antifungal agents or douching for 48–72 hours before sampling
• No fasting required; collect sample at home during scheduled appointment
• Provide valid Emirates ID and consent for home collection within Dubai